Sign Up
bf/NASDAQ:CERE_icon.jpeg

COM:CEREVEL

Cerevel Therapeutics

  • Stock

Last Close

44.63

31/07 20:00

Market Cap

7.46B

Beta: -

Volume Today

15.03M

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Aug '14
Aug '15
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.78
-
2.01
158.25%
cash conversion cycle
-450.55
-
-227.63
49.48%
cash per share
1.97
-
0.57
71.09%
0.63
10.07%
5.21
732.44%
4.14
20.49%
5.90
42.38%
9.66
63.81%
company equity multiplier
0.11
-
0.32
187.12%
1.55
382.29%
1.16
25.40%
1.19
2.80%
1.95
64.04%
1.85
5.50%
days of inventory outstanding
10.15
-
days of payables outstanding
516.87
-
305.06
40.98%
769.50
-
days of sales outstanding
56.18
-
77.43
37.83%
dividend yield
ebit per revenue
-12.17
-
-10.36
14.88%
ebt per ebit
1.00
-
1.00
0.29%
1.54
53.89%
1.02
33.64%
1.02
0.33%
0.96
6.70%
0.97
1.20%
effective tax rate
0.00
-
0.00
4.14%
-0.00
1,087.17%
0.00
144.98%
0.01
8,026.00%
-0.00
103.55%
-0.00
155.48%
enterprise value multiple
-5.99
-
-6.03
0.75%
-39.67
557.48%
-5.84
85.29%
-19.41
232.48%
-13.60
29.94%
-14.40
5.94%
fixed asset turnover
0.80
-
2.16
169.46%
free cash flow per share
-1.66
-
-1.66
0.11%
-0.56
65.92%
-1.86
228.55%
-1.38
25.43%
-1.96
41.91%
-2.14
8.72%
gross profit margin
-0.26
-
-0.94
264.85%
interest coverage
-430.25
-
-939.23
118.30%
-38.24
-
-42.33
10.68%
inventory turnover
35.96
-
long term debt to capitalization
0.13
-
0.51
280.86%
0.25
51.25%
0.07
70.08%
0.06
25.33%
0.41
641.95%
0.40
3.08%
net income per ebt
1.00
-
1.00
0.00%
1.00
0.03%
1.00
0.05%
0.99
1.27%
1.00
1.34%
1.00
0.07%
net profit margin
-12.20
-
-10.35
15.13%
operating cash flow per share
-1.58
-
-1.63
2.90%
-0.56
65.88%
-1.60
187.55%
-1.31
18.28%
-1.94
48.26%
-2.11
8.98%
operating cycle
66.33
-
77.43
16.74%
operating profit margin
-12.17
-
-10.36
14.88%
payables turnover
0.71
-
1.20
69.44%
0.47
-
pretax profit margin
-12.20
-
-10.35
15.13%
price fair value
6.14
-
40.22
555.33%
19.44
51.67%
3.18
83.66%
7.65
140.94%
9.15
19.63%
10.20
11.42%
receivables turnover
6.50
-
4.71
27.45%
return on assets
-9.47
-
-20.76
119.18%
-1.06
94.88%
-0.34
67.85%
-0.32
5.50%
-0.35
6.96%
-0.35
0.81%
return on capital employed
17.98
-
7.29
59.47%
-0.79
110.81%
-0.36
54.48%
-0.34
5.07%
-0.39
14.29%
-0.39
0.15%
return on equity
-1.06
-
-6.68
529.29%
-1.65
75.31%
-0.40
76.02%
-0.38
2.86%
-0.67
75.45%
-0.64
4.74%
total debt to capitalization
0.13
-
0.51
280.86%
0.27
47.66%
0.08
70.44%
0.06
24.86%
0.41
598.44%
0.40
3.09%

All numbers in (except ratios and percentages)